Optical Coherence Tomography Angiography Biomarkers as Indicators of Cardiovascular Disease

Rebecca L. Kellner,Alon Harris,Lauren Ciulla,Giovanna Guidoboni,Alice Verticchio Vercellin,Francesco Oddone,Carmela Carnevale,Mohamed Zaid,Gal Antman,Jeffrey T. Kuvin,Brent Siesky
DOI: https://doi.org/10.3390/jcm13030829
IF: 3.9
2024-02-01
Journal of Clinical Medicine
Abstract:Alterations in microvasculature represent some of the earliest pathological processes across a wide variety of human diseases. In many organs, however, inaccessibility and difficulty in directly imaging tissues prevent the assessment of microvascular changes, thereby significantly limiting their translation into improved patient care. The eye provides a unique solution by allowing for the non-invasive and direct visualization and quantification of many aspects of the human microvasculature, including biomarkers for structure, function, hemodynamics, and metabolism. Optical coherence tomography angiography (OCTA) studies have specifically identified reduced capillary densities at the level of the retina in several eye diseases including glaucoma. This narrative review examines the published data related to OCTA-assessed microvasculature biomarkers and major systemic cardiovascular disease. While loss of capillaries is being established in various ocular disease, pilot data suggest that changes in the retinal microvasculature, especially within the macula, may also reflect small vessel damage occurring in other organs resulting from cardiovascular disease. Current evidence suggests retinal microvascular biomarkers as potential indicators of major systemic cardiovascular diseases, including systemic arterial hypertension, atherosclerotic disease, and congestive heart failure.
medicine, general & internal
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve The main purpose of this paper is to analyze data related to the assessment of retinal microvasculature (including the macular and peripapillary regions) using Optical Coherence Tomography Angiography (OCTA) as potential prognostic indicators for systemic cardiovascular diseases (including systemic hypertension, atherosclerotic disease, and congestive heart failure). #### Specific Content Summary: 1. **Background**: - Cardiovascular diseases (CVD) are one of the leading causes of death globally, accounting for approximately 32% of all deaths, with myocardial infarction and stroke comprising 85% of these. - Despite its high prevalence and significant social impact, developing new non-invasive diagnostic and prognostic methods remains challenging due to difficulties in tissue acquisition and direct visualization of small vessels. 2. **Uniqueness of Ocular Microvasculature**: - The microvascular network of the eye can be non-invasively and directly visualized, imaged, and quantified. - Using ocular vasculature to assess pathological changes in the retinal microvascular bed as indicators of systemic vascular pathophysiology has been explored in preliminary studies. - Changes in retinal microvasculature, particularly in the macular region, as well as changes in retinal thickness and layering, are associated with various aspects of cardiovascular health. 3. **Application of OCTA Technology**: - OCTA is an advanced imaging platform that provides structural biomarkers and enables three-dimensional assessment of both large and small vessels within the retina and choroid. - OCTA can measure vascular density (VD) in the optic nerve area and provide visualization of superficial and deep capillary plexuses in the macular region. - OCTA studies have found reduced capillary density in the macular region in patients with hypertension and retinal detachment, corresponding to changes in vascular density (VD) and signal strength. 4. **Research Objectives**: - Analyze available data to explore the potential of retinal microvasculature assessed by OCTA (in the macular and peripapillary regions) as prognostic indicators for systemic cardiovascular diseases. Through these studies, the paper aims to utilize OCTA technology in clinical settings to assess ocular microvasculature, better understand the health of the systemic cardiovascular system, and improve diagnostic and early intervention outcomes.